Skip to main content
. 2021 Oct 8;23(Suppl E):E151–E155. doi: 10.1093/eurheartj/suab114

Table 2.

Labs and vitals

Variables Omecamtiv mercabil Placebo Relative risk or difference
(n = 4110) (n = 4101) (95% CI)
Variation form baseline
Systolic arterial pressure
 Week 24 1.4 ± 15.3 1.5 ± 15.6 −0.1 (−0.9 to 0.6)
 Week 48 2.0 ± 16.1 1.9 ± 16.0 0.2 (−0.6 to 1.0)
Heart rate
 Week 24 −2.1 ± 12.6 −0.5 ± 12.8 −1.6 (−2.2 to  − 1.0)
 Week 48 −2.0 ± 13.1 −0.2 ± 13.2 −1.8 (−2.4 to  − 1.1)
Potassium
 Week 24 −0.01 ± 0.57 −0.01 ± 0.57 0.00 (−0.03 to 0.03)
 Week 48 −0.03 ± 0.59 −0.02 ± 0.58 −0.01 (−0.04 to 0.02)
NT-proBNP
 Week 24 −251 (−1180 to 295) −180 (−915 to 441) 0.90 (0.86 to 0.94)
Troponin I
 Week 24 4 (−2 to 21) 0 (−9 to 8) 4 (3 to 5)
 Week 48 2 (−4 to 18) 0 (−9 to 8) 2 (1 to 3)